Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06220747

Effectiveness of HPV Vaccine Among Adolescents and Reproductive Women

Effectiveness of Single Dose or Two Doses of HPV Vaccine Among Adolescents and Reproductive Women: A Test-negative Control Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
760 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
Female
Age
12 Years – 45 Years
Healthy volunteers
Accepted

Summary

To assess the effectiveness of HPV vaccine 2 doses or less to prevent HPV high risk infection among adolescents and adults. We conduct the test-negative control study including 12-45 women who interest to do a check-up pap smear. Cases were women who met the inclusion criteria and tested positive for HPV DNA, and controls were defined as women who met inclusion criteria but tested negative. For the proposed HPV VE study, we will enroll nine controls for each enrolled case. The participants will be interviewed about their demographics and vaccine histories. Potential confounders data will be collected by interview or self- report questionnaire. HPV DNA test will be done by urine or self-cervical sampling (optional). In case the participant has previous HPV test result within 1 year, the result will be recorded and analysed without repeating the test.

Conditions

Timeline

Start date
2024-03-29
Primary completion
2025-03-01
Completion
2025-06-01
First posted
2024-01-24
Last updated
2024-10-09

Locations

2 sites across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06220747. Inclusion in this directory is not an endorsement.